191 related articles for article (PubMed ID: 20229566)
1. A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety.
Boxer MB; Quinn AM; Shen M; Jadhav A; Leister W; Simeonov A; Auld DS; Thomas CJ
ChemMedChem; 2010 May; 5(5):730-8. PubMed ID: 20229566
[TBL] [Abstract][Full Text] [Related]
2. (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18.
Wannamaker W; Davies R; Namchuk M; Pollard J; Ford P; Ku G; Decker C; Charifson P; Weber P; Germann UA; Kuida K; Randle JC
J Pharmacol Exp Ther; 2007 May; 321(2):509-16. PubMed ID: 17289835
[TBL] [Abstract][Full Text] [Related]
3. Structure-based combinatorial library design: discovery of non-peptidic inhibitors of caspases 3 and 8.
Head MS; Ryan MD; Lee D; Feng Y; Janson CA; Concha NO; Keller PM; deWolf WE
J Comput Aided Mol Des; 2001 Dec; 15(12):1105-17. PubMed ID: 12160093
[TBL] [Abstract][Full Text] [Related]
4. Conformationally constrained inhibitors of caspase-1 (interleukin-1 beta converting enzyme) and of the human CED-3 homologue caspase-3 (CPP32, apopain).
Karanewsky DS; Bai X; Linton SD; Krebs JF; Wu J; Pham B; Tomaselli KJ
Bioorg Med Chem Lett; 1998 Oct; 8(19):2757-62. PubMed ID: 9873617
[TBL] [Abstract][Full Text] [Related]
5. Active Site Mapping of Human Cathepsin F with Dipeptide Nitrile Inhibitors.
Schmitz J; Furtmann N; Ponert M; Frizler M; Löser R; Bartz U; Bajorath J; Gütschow M
ChemMedChem; 2015 Aug; 10(8):1365-77. PubMed ID: 26119278
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel Pd-catalyzed N-acyl vinylogous carbamate synthesis for the key intermediate of ICE inhibitor VX-765.
Tanoury GJ; Chen M; Dong Y; Forslund RE; Magdziak D
Org Lett; 2008 Jan; 10(2):185-8. PubMed ID: 18081302
[TBL] [Abstract][Full Text] [Related]
7. Identification of specific tethered inhibitors for caspase-5.
Gao J; Wells JA
Chem Biol Drug Des; 2012 Feb; 79(2):209-15. PubMed ID: 22014003
[TBL] [Abstract][Full Text] [Related]
8. Structure-based discovery of a novel non-peptidic small molecular inhibitor of caspase-3.
Sakai J; Yoshimori A; Nose Y; Mizoroki A; Okita N; Takasawa R; Tanuma S
Bioorg Med Chem; 2008 May; 16(9):4854-9. PubMed ID: 18387304
[TBL] [Abstract][Full Text] [Related]
9. Succinic acid amides as P2-P3 replacements for inhibitors of interleukin-1beta converting enzyme (ICE or caspase 1).
Galatsis P; Caprathe B; Gilmore J; Thomas A; Linn K; Sheehan S; Harter W; Kostlan C; Lunney E; Stankovic C; Rubin J; Brady K; Allen H; Talanian R
Bioorg Med Chem Lett; 2010 Sep; 20(17):5184-90. PubMed ID: 20656488
[TBL] [Abstract][Full Text] [Related]
10. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
Falgueyret JP; Oballa RM; Okamoto O; Wesolowski G; Aubin Y; Rydzewski RM; Prasit P; Riendeau D; Rodan SB; Percival MD
J Med Chem; 2001 Jan; 44(1):94-104. PubMed ID: 11141092
[TBL] [Abstract][Full Text] [Related]
11. Selective and sensitive monitoring of caspase-1 activity by a novel bioluminescent activity-based probe.
Kindermann M; Roschitzki-Voser H; Caglic D; Repnik U; Miniejew C; Mittl PR; Kosec G; Grütter MG; Turk B; Wendt KU
Chem Biol; 2010 Sep; 17(9):999-1007. PubMed ID: 20851349
[TBL] [Abstract][Full Text] [Related]
12. Dipeptide-derived nitriles containing additional electrophilic sites: potentially irreversible inhibitors of cysteine proteases.
Löser R; Gütschow M
J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1245-52. PubMed ID: 19912058
[TBL] [Abstract][Full Text] [Related]
13. Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors.
Maillard MC; Brookfield FA; Courtney SM; Eustache FM; Gemkow MJ; Handel RK; Johnson LC; Johnson PD; Kerry MA; Krieger F; Meniconi M; Muñoz-Sanjuán I; Palfrey JJ; Park H; Schaertl S; Taylor MG; Weddell D; Dominguez C
Bioorg Med Chem; 2011 Oct; 19(19):5833-51. PubMed ID: 21903398
[TBL] [Abstract][Full Text] [Related]
14. Noncovalent tripeptidyl benzyl- and cyclohexyl-amine inhibitors of the cysteine protease caspase-1.
Löser R; Abbenante G; Madala PK; Halili M; Le GT; Fairlie DP
J Med Chem; 2010 Mar; 53(6):2651-5. PubMed ID: 20170165
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: peptidomimetic replacement of the P2 alpha-amino acid by a alpha-hydroxy acid.
Wang Y; Guan L; Jia S; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2005 Mar; 15(5):1379-83. PubMed ID: 15713391
[TBL] [Abstract][Full Text] [Related]
16. New Caspase-1 inhibitor by scaffold hopping into bio-inspired 3D-fragment space.
Brethon A; Chantalat L; Christin O; Clary L; Fournier JF; Gastreich M; Harris CS; Isabet T; Pascau J; Thoreau E; Roche D; Rodeschini V
Bioorg Med Chem Lett; 2017 Dec; 27(24):5373-5377. PubMed ID: 29157864
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach.
Lakshmi PJ; Kumar BV; Nayana RS; Mohan MS; Bolligarla R; Das SK; Bhanu MU; Kondapi AK; Ravikumar M
Bioorg Med Chem; 2009 Aug; 17(16):6040-7. PubMed ID: 19631549
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics.
Dragovich PS; Prins TJ; Zhou R; Fuhrman SA; Patick AK; Matthews DA; Ford CE; Meador JW; Ferre RA; Worland ST
J Med Chem; 1999 Apr; 42(7):1203-12. PubMed ID: 10197964
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of warheads for design of cysteine protease inhibitors.
Silva DG; Ribeiro JFR; De Vita D; Cianni L; Franco CH; Freitas-Junior LH; Moraes CB; Rocha JR; Burtoloso ACB; Kenny PW; Leitão A; Montanari CA
Bioorg Med Chem Lett; 2017 Nov; 27(22):5031-5035. PubMed ID: 29054358
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
